Your browser doesn't support javascript.
loading
An Update on Neurofibromatosis Type 1-Associated Gliomas.
Lobbous, Mina; Bernstock, Joshua D; Coffee, Elizabeth; Friedman, Gregory K; Metrock, Laura K; Chagoya, Gustavo; Elsayed, Galal; Nakano, Ichiro; Hackney, James R; Korf, Bruce R; Nabors, Louis B.
Afiliação
  • Lobbous M; Division of Neuro Oncology, Department of Neurology, University of Alabama at Birmingham, 510 20th Street South, Faculty Office Tower suite 1020 Birmingham, Birmingham, AL 35294, USA.
  • Bernstock JD; Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
  • Coffee E; Division of Neuro Oncology, Department of Neurology, University of Alabama at Birmingham, 510 20th Street South, Faculty Office Tower suite 1020 Birmingham, Birmingham, AL 35294, USA.
  • Friedman GK; Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Metrock LK; Division of Pediatric Hematology and Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Chagoya G; Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Elsayed G; Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Nakano I; Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Hackney JR; Department of Pathology, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Korf BR; Department of Genetics, University of Alabama at Birmingham, Birmingham, AL 35294, USA.
  • Nabors LB; Division of Neuro Oncology, Department of Neurology, University of Alabama at Birmingham, 510 20th Street South, Faculty Office Tower suite 1020 Birmingham, Birmingham, AL 35294, USA.
Cancers (Basel) ; 12(1)2020 Jan 01.
Article em En | MEDLINE | ID: mdl-31906320
Neurofibromatosis type 1 (NF1) is an autosomal dominant tumor predisposition syndrome that affects children and adults. Individuals with NF1 are at high risk for central nervous system neoplasms including gliomas. The purpose of this review is to discuss the spectrum of intracranial gliomas arising in individuals with NF1 with a focus on recent preclinical and clinical data. In this review, possible mechanisms of gliomagenesis are discussed, including the contribution of different signaling pathways and tumor microenvironment. Furthermore, we discuss the recent notable advances in the developing therapeutic landscape for NF1-associated gliomas including clinical trials and collaborative efforts.
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos